| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 48.5892 | 43 |
| GSM780708 | Untreated after 4 days (C2_1) | 41.3242 | 11 |
| GSM780709 | Untreated after 4 days (C3_1) | 51.9397 | 54 |
| GSM780719 | Untreated after 4 days (C1_2) | 52.3119 | 55 |
| GSM780720 | Untreated after 4 days (C2_2) | 50.8408 | 51 |
| GSM780721 | Untreated after 4 days (C3_2) | 54.7535 | 59 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 43.8914 | 22 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 48.0646 | 41 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 47.1535 | 37 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 38.6765 | 4 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 47.0443 | 37 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 47.412 | 39 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 44.3897 | 24 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 44.2947 | 24 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 45.2286 | 28 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 46.3918 | 34 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 43.1293 | 18 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 48.5004 | 43 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 44.1299 | 23 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 49.5018 | 47 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 50.9804 | 51 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 56.0731 | 61 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 47.8054 | 40 |